Similarly, NK cells in the tumor-draining lymph nodes also express surface PD-L1 and have been shown to have improved antitumor effects in leukemia [62] and hepatocellular carcinoma [67] when exposed to a combination of cell-activating cytokines and anti-PD-L1 antibodies. The gene discussed is CD274; the disease is neoplasm.